SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,002

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

November 30, 2011

Conditions
StentsCoronary Artery DiseaseTotal Coronary OcclusionCoronary Artery RestenosisStent ThrombosisVascular DiseaseMyocardial IschemiaCoronary Artery Stenosis
Interventions
DEVICE

XIENCE V® Everolimus Eluting Coronary Stent

Drug eluting stent implantation stent in the treatment of coronary artery disease.

DEVICE

TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent

Drug eluting stent implantation stent in the treatment of coronary artery disease.

Trial Locations (65)

10032

Columbia University Medical Center, New York

11040

Long Island Jewish Medical Center, New Hyde Park

13203

St. Joseph's Hospital Health Center, Syracuse

15212

Allegheny General Hospital, Pittsburgh

17043

Pinnacle Health @ Harrisburg Hospital, Harrisburg

20010

Washington Hospital Center, Washington D.C.

20912

Washington Adventist Hospital, Takoma Park

21204

St. Joseph Medical Center, Towson

21287

Johns Hopkins Hospital, Baltimore

27157

Wake Forest University Baptist Medical Center, Winston-Salem

27610

Wake Medical Center, Raleigh

27710

Duke University Medical Center, Durham

28204

Presbyterian Hospital, Albuquerque

29403

Medical University of South Carolina, Charleston

30308

Emory Crawford Long Hospital, Atlanta

30309

Piedmont Hospital, Atlanta

30342

Saint Joseph's Hospital of Atlanta, Atlanta

33176

Baptist Hospital of Miami, Miami

33308

Holy Cross Medical Center (prev. North Ridge MC), Fort Lauderdale

35211

Baptist Medical Center Princeton, Birmingham

35213

Baptist Health System - Montclair, Birmingham

38801

North Mississippi Medical Center, Tupelo

40202

Jewish Hospital, Louisville

43214

Riverside Methodist Hospital, Columbus

44035

EMH Regional Medical Center, Elyria

45219

The Christ Hospital, Cincinnati

46290

The Heart Center of IN, LLC, Indianapolis

48236

St John Hospital & Medical Center, Detroit

49048

Borgess Medical Center, Kalamazoo

49503

Spectrum Health Hospital, Grand Rapids

49770

Northern Michigan Hospital, Petoskey

53215

St. Luke's Medical Center, Milwaukee

55407

Abbott Northwestern Hospital, Minneapolis

59802

St. Patrick Hospital, Missoula

60148

Elmhurst Memorial Hospital, Elmhurst

60612

Rush University Medical Center, Chicago

62701

St. John's Hospital, Springfield

63110

Barnes Jewish Hospital, St Louis

64111

St. Luke's Hospital, Kansas City

68526

Nebraska Heart Hospital, Lincoln

70121

Ochsner Clinic Foundation, New Orleans

73104

The University of Oklahoma Health Sciences Center, Oklahoma City

73112

Integris Baptist Medical, Inc., Oklahoma City

75230

Medical City Dallas Hospital, Dallas

77030

Methodist Hospital, Houston

78215

TexSan Heart Hospital, San Antonio

78756

Heart Hospital of Austin, Austin

80528

Poudre Valley Hospital, Fort Collins

85016

Arizona Heart Hospital, Phoenix

87106

Good Samaritan Hospital, Los Angeles

Presbyterian Hospital, Charlotte

92037

Scripps Memorial Hospital, La Jolla

94609

Alta Bates Summit Medical Center, Oakland

95819

Mercy General Hospital, Sacramento

97225

Providence St. Vincent Medical Center, Portland

97401

Sacred Heart Medical Center, Eugene

98104

Swedish Medical Center, Seattle

02115

Brigham & Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

03756

Dartmouth-Hitchcock Medical Center, Lebanon

07601

Hackensack Medical Center, Hackensack

07450

The Valley Hospital, Ridgewood

02903

Rhode Island Hospital, Providence

02906

The Miriam Hospital, Providence

05401

Fletcher Allen Health Care, Burlington

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00180479 - SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) | Biotech Hunter | Biotech Hunter